![](/img/cover-not-exists.png)
The future of Febuxostat after the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) trial: who CARES?
Katsiki, Niki, Borghi, ClaudioLanguage:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1080/14656566.2018.1532503
Date:
October, 2018
File:
PDF, 852 KB
english, 2018